# Newborn Hearing Screening Benefits Children, But Global Disparities Persist

**Authors:** Katrin Neumann, Philipp Mathmann, Shelly Chadha, Harald A. Euler, Karl R. White

PMC · DOI: 10.3390/jcm11010271 · Journal of Clinical Medicine · 2022-01-05

## TL;DR

Newborn hearing screening helps children with hearing loss, but many countries still lack effective programs.

## Contribution

A global survey reveals significant disparities in newborn hearing screening implementation across countries.

## Key findings

- 38% of newborns and infants globally have no or minimal hearing screening.
- 33% of countries screen at least 85% of newborns, indicating partial progress toward universal screening.
- Screening programs vary widely in quality and access to follow-up services for children with hearing loss.

## Abstract

There is substantial evidence that newborn hearing screening (NHS) reduces the negative sequelae of permanent childhood hearing loss (PCHL) if performed in programs that aim to screen all newborns in a region or nation (often referred to as Universal Newborn Hearing Screening or UNHS). The World Health Organization (WHO) has called in two resolutions for the implementation of such programs and for the collection of large-scale data. To assess the global status of NHS programs we surveyed individuals potentially involved with newborn and infant hearing screening (NIHS) in 196 countries/territories (in the following text referred to as countries). Replies were returned from 158 countries. The results indicated that 38% of the world’s newborns and infants had no or minimal hearing screening and 33% screened at least 85% of the babies (hereafter referred to as UNHS). Hearing screening programs varied considerably in quality, data acquisition, and accessibility of services for children with PCHL. In this article, we summarize the main results of the survey in the context of several recent WHO publications, particularly the World Report on Hearing, which defined advances in the implementation of NHS programs in the Member States as one of three key indicators of worldwide progress in ear and hearing care (EHC).

## Full-text entities

- **Diseases:** NIHS (MESH:D007232), premature death (MESH:D003643), anxiety (MESH:D001007), CMV infections (MESH:D003586), hard of hearing (MESH:D018804), ototoxic drugs (MESH:D000081015), deficits in language, cognitive, psychosocial (MESH:D007806), Deafness (MESH:D003638), disability (MESH:D009069), sensorineural hearing loss (MESH:D006319), infected (MESH:D007239), EHC (MESH:D004427), congenital health problems (MESH:D000076082), syndromic and non-syndromic hearing disorders (MESH:C537845), unilateral hearing loss (MESH:D046088), Hearing Impairment (MESH:D034381), disorders (MESH:D009358), visual, neurologic, endocrinologic (MESH:D014786)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8746089/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8746089/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC8746089/full.md

---
Source: https://tomesphere.com/paper/PMC8746089